Economic benefit of prescribing an adjusted renal dose of dipeptidyl peptidase IV inhibitors in type 2 diabetes patients with chronic kidney disease

Sun Joon Moon; Young Min Cho

doi:10.1111/1753-0407.13067

Economic benefit of prescribing an adjusted renal dose of dipeptidyl peptidase IV inhibitors in type 2 diabetes patients with chronic kidney disease

Sun Joon Moon
, Young Min Cho

Seoul National University
Kangbuk Samsung Hospital

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	645-648
Number of pages	4
Journal	Journal of Diabetes
Volume	12
Issue number	9
DOIs	https://doi.org/10.1111/1753-0407.13067
State	Published - 1 Sep 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

cost analysis
dipeptidyl peptidase IV inhibitors
renal insufficiency

Access to Document

10.1111/1753-0407.13067

Cite this

@article{4d3ca255b4b4430096dc7df42801774c,

title = "Economic benefit of prescribing an adjusted renal dose of dipeptidyl peptidase IV inhibitors in type 2 diabetes patients with chronic kidney disease",

keywords = "cost analysis, dipeptidyl peptidase IV inhibitors, renal insufficiency",

author = "Moon, \{Sun Joon\} and Cho, \{Young Min\}",

year = "2020",

month = sep,

day = "1",

doi = "10.1111/1753-0407.13067",

language = "English",

volume = "12",

pages = "645--648",

journal = "Journal of Diabetes",

issn = "1753-0393",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Economic benefit of prescribing an adjusted renal dose of dipeptidyl peptidase IV inhibitors in type 2 diabetes patients with chronic kidney disease

AU - Moon, Sun Joon

AU - Cho, Young Min

PY - 2020/9/1

Y1 - 2020/9/1

KW - cost analysis

KW - dipeptidyl peptidase IV inhibitors

KW - renal insufficiency

UR - https://www.scopus.com/pages/publications/85087145049

U2 - 10.1111/1753-0407.13067

DO - 10.1111/1753-0407.13067

M3 - Article

C2 - 32436296

AN - SCOPUS:85087145049

SN - 1753-0393

VL - 12

SP - 645

EP - 648

JO - Journal of Diabetes

JF - Journal of Diabetes

IS - 9

ER -

Economic benefit of prescribing an adjusted renal dose of dipeptidyl peptidase IV inhibitors in type 2 diabetes patients with chronic kidney disease

UN SDGs

Keywords

Access to Document

Other files and links

Cite this